M. Xia
发表
Tian Tian,
Hanyu Ma,
S. Liang,
2016,
Oncotarget.
Weiqi Wang,
Yuwen Pan,
M. Xia,
2021,
Cell Death & Disease.
Weiqi Wang,
Yuwen Pan,
M. Xia,
2022,
Oncogene.
M. Xia,
S. Yao,
Yuan Zhu,
2020,
Cell Death & Disease.
M. Xia,
S. Yao,
Pan Liu,
2020,
Cancer Cell International.
Jun Yu Li,
Peng Guo,
Jing Wang,
2017,
Oncology reports.
Tian Tian,
Hanyu Ma,
Xubin Liu,
2019,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
J. Li,
Peng Guo,
M. Xia,
2018,
Oncology letters.
Wei Wang,
Hao Tan,
M. Xia,
2022,
Cell Death & Disease.
Peng Guo,
Jing Wang,
Wen Li,
2015,
Tumor Biology.
TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
L. Liu,
J. Liu,
M. Xia,
2014,
British Journal of Cancer.
Meilian Chen,
M. Xia,
Peisong Chen,
2022,
Frontiers in Oncology.
Jing Wang,
M. Xia,
Weijing Zhang,
2014,
Medical Oncology.
M. Xia,
S. Yao,
Junxiu Liu,
2016,
Oncotarget.
Hanyu Ma,
Xubin Liu,
M. Xia,
2017,
Diagnostic cytopathology.
Yanchun Liang,
J. Li,
Yuwen Pan,
2023,
Oncogene.
D. Shen,
M. Xia,
M. He,
2020,
Zhonghua fu chan ke za zhi.
Hanyu Ma,
Xubin Liu,
M. Xia,
2020,
Infectious Agents and Cancer.
C. Duan,
S. Liang,
Xubin Liu,
2014,
Journal of cellular and molecular medicine.
Hanyu Ma,
Xubin Liu,
M. Xia,
2020,
Infectious Agents and Cancer.
Yuwen Pan,
M. Xia,
Hongye Jiang,
2021,
Stem cells international.
M. Xia,
Run Chen,
M. He,
2021,
Future oncology.